Millipore Sigma Vibrant Logo

239804 Cyclopamine-KAAD - Calbiochem

Descripción

Replacement Information

Tabla espec. clave

Empirical Formula
C₄₄H₆₃N₃O₄

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
239804-100UG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Frasco de vidrio 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      Description
      OverviewA potent, cell-permeable analog of Cyclopamine (Cat. No. 239803) that specifically inhibits the Hedgehog (Hh) signaling with similar or lower toxicity (IC50 = 20 nM in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells). Binds to SmoA1 and promotes its exit from the endoplasmic reticulum. Suppresses both the ShhNp-induced pathway activity and SmoA1-induced reporter activity. Shown to sensitize human glioma cells to TRAIL-induced apoptosis. Also available as a 1 mM solution in DMSO (Cat. No. 239807).
      Catalogue Number239804
      Brand Family Calbiochem®
      Synonyms3-Keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine, KAAD-Cyclopamine, Shh Signaling Antagonist II
      References
      ReferencesSiegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.
      Product Information
      ATP CompetitiveN
      FormWhite to light yellow solid
      Hill FormulaC₄₄H₆₃N₃O₄
      Chemical formulaC₄₄H₆₃N₃O₄
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetHh signaling in Shh-light2 assay
      Primary Target IC<sub>50</sub>20 nM against Hedgehog (Hh) signaling in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells
      Purity≥70% by HPLC (sum of two isomers)
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 22-36/37

      Do not breathe dust.
      Wear suitable protective clothing and gloves.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Harmful
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      239804-100UG 04055977198881

      Documentation

      Cyclopamine-KAAD - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Cyclopamine-KAAD - Calbiochem Certificados de análisis

      CargoNúmero de lote
      239804

      Referencias bibliográficas

      Visión general referencias
      Siegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.

      Ficha técnica

      Cargo
      Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

      Citas

      Título
    • Siegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
    • Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision23-October-2024 JSW
      Synonyms3-Keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine, KAAD-Cyclopamine, Shh Signaling Antagonist II
      DescriptionA cell-permeable potent analog of Cyclopamine (Cat. No. 239803) that specifically inhibits Hedgehog (Hh) signaling with similar or lower toxicity (IC50 = 20 nM in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells). Binds to SmoA1 and promotes its exit from the endoplasmic reticulum. Suppresses both ShhNp-induced pathway activity and SmoA1-induced reporter activity. Reported to cause regression of murine tumor allografts in vivo and induce rapid cell death in human medulloblastoma. Shown to sensitize human glioma cells to TRAIL-induced apoptosis.
      FormWhite to light yellow solid
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₄₄H₆₃N₃O₄
      Structure formulaStructure formula
      Purity≥70% by HPLC (sum of two isomers)
      SolubilityDMSO (5 mg/ml), Ethanol (1 mg/ml), or Methanol (1 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
      Toxicity Harmful
      ReferencesSiegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.
      Citation
    • Siegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.